Dr. Krug is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
MSKCC, Dept Thoracic Oncology
New York, NY 10021Phone+1 646-227-3813- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
- Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1997
- Washington University in St. Louis School of MedicineClass of 1994
Certifications & Licensure
- NY State Medical License 1997 - 2025
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2010-2014
Clinical Trials
- 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Start of enrollment: 1999 Jul 01
- Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy Start of enrollment: 1998 Aug 01
- Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer Start of enrollment: 1999 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Population Pharmacokinetics and Exposure-Response Analysis for the CTLA-4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON Study.Jimmy Zhijian He, Vincent Duval, Petra Jauslin, Antonio Gonçalves, Aburough Abegesah, Chunling Fan, KyoungSoo Lim, Xuyang Song, Cecil Chen, Xiaojin Shi, Helen Mann, Le...> ;Clinical Pharmacology and Therapeutics. 2023 Dec 1
- 12 citationsPhase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer.Peter E Hall, Neal Ready, Amanda Johnston, John S. Bomalaski, Ralph Venhaus, Michael Sheaff, Lee M. Krug, Peter W. Szlosarek> ;Clinical Lung Cancer. 2020 Jul 30
- 24 citationsReal-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum Chemotherapy.Lee S. Schwartzberg, Beata Korytowsky, John R. Penrod, Ying Zhang, T. Kim Le, Cory Batenchuk, Lee M. Krug> ;Clinical Lung Cancer. 2019 Apr 19
- Join now to see all
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
- The Mount Sinai HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: